Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Iradimed Cp (IRMD)

Iradimed Cp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 511,119
  • Shares Outstanding, K 12,664
  • Annual Sales, $ 65,560 K
  • Annual Income, $ 17,190 K
  • 60-Month Beta 0.82
  • Price/Sales 7.82
  • Price/Cash Flow 28.81
  • Price/Book 7.24
Trade IRMD with:

Options Overview Details

View History
  • Implied Volatility 51.52% ( +0.91%)
  • Historical Volatility 25.94%
  • IV Percentile 78%
  • IV Rank 80.87%
  • IV High 61.51% on 10/10/23
  • IV Low 9.26% on 12/21/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 179
  • Open Int (30-Day) 175

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.29
  • Number of Estimates 1
  • High Estimate 0.29
  • Low Estimate 0.29
  • Prior Year 0.27
  • Growth Rate Est. (year over year) +7.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.18 +2.04%
on 04/19/24
44.99 -8.87%
on 03/21/24
-3.57 (-8.01%)
since 03/19/24
3-Month
40.18 +2.04%
on 04/19/24
47.76 -14.15%
on 02/16/24
-3.37 (-7.60%)
since 01/19/24
52-Week
36.12 +13.51%
on 10/16/23
51.04 -19.67%
on 06/20/23
-0.05 (-0.12%)
since 04/19/23

Most Recent Stories

More News
IRadimed: Q4 Earnings Snapshot

IRadimed: Q4 Earnings Snapshot

IRMD : 41.00 (+1.59%)
IRadimed: Q3 Earnings Snapshot

IRadimed: Q3 Earnings Snapshot

IRMD : 41.00 (+1.59%)
IRadimed: Q2 Earnings Snapshot

IRadimed: Q2 Earnings Snapshot

IRMD : 41.00 (+1.59%)
IRadimed (IRMD) Surpasses Q1 Earnings and Revenue Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 11.11% and 4.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

IRMD : 41.00 (+1.59%)
DYNT : 0.5320 (-4.37%)
IRadimed: Q1 Earnings Snapshot

IRadimed: Q1 Earnings Snapshot

IRMD : 41.00 (+1.59%)
Select Medical (SEM) Buys Richmond Post-Acute Care Facility

Select Medical (SEM) acquires the Vibra Hospital of Richmond to provide enhanced critical illness recovery care across Virginia.

AMPH : 40.01 (+3.52%)
PODD : 166.25 (+0.92%)
SEM : 27.06 (+2.38%)
IRMD : 41.00 (+1.59%)
Zacks.com featured highlights include MercadoLibre, iRadimed, Northeast Community Bancorp and AAON

MercadoLibre, iRadimed, Northeast Community Bancorp and AAON are part of the Zacks Screen of the Week article.

AAON : 85.41 (+0.20%)
MELI : 1,356.43 (-1.01%)
IRMD : 41.00 (+1.59%)
NECB : 15.34 (+1.99%)
4 Best Profitable Stocks to Buy Banking on Net Income Ratio

MercadoLibre (MELI), iRadimed (IRMD), Northeast Community Bancorp (NECB) and AAON (AAON) have been selected as the top picks with a high net income ratio.

AAON : 85.41 (+0.20%)
MELI : 1,356.43 (-1.01%)
IRMD : 41.00 (+1.59%)
NECB : 15.34 (+1.99%)
IRadimed (IRMD) Q4 Earnings Top Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 3.23% and 0.44%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

IRMD : 41.00 (+1.59%)
RWLK : 1.0501 (+6.07%)
IRadimed: Q4 Earnings Snapshot

IRadimed: Q4 Earnings Snapshot

IRMD : 41.00 (+1.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

3rd Resistance Point 42.78
2nd Resistance Point 42.10
1st Resistance Point 41.55
Last Price 41.00
1st Support Level 40.32
2nd Support Level 39.63
3rd Support Level 39.08

See More

52-Week High 51.04
Fibonacci 61.8% 45.34
Fibonacci 50% 43.58
Fibonacci 38.2% 41.82
Last Price 41.00
52-Week Low 36.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar